Biochimica Et Biophysica Acta-reviews On Cancer

雜志介紹

Biochimica Et Biophysica Acta-reviews On Cancer雜志介紹

《Biochimica Et Biophysica Acta-reviews On Cancer》是一本以Dutch為主的未開放獲取國際優秀期刊，中文名稱Biochimica Et Biophysica Acta——癌癥評論，本刊主要出版、報道醫學-BIOCHEMISTRY & MOLECULAR BIOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為9.7，最新CiteScore 指數為17.2。

本刊近期中國學者發表的論文主要有：

• The expression of FOXP3 and its role in human cancers

  Author: Hao Jia, Haolong Qi, Zhongqin Gong, Shucai Yang, Jianwei Ren, Yi Liu, Ming-Yue Li, George Gong Chen

• Targeting mitosis exit: A brake for cancer cell proliferation

  Author: Xinran Liu, Yuchen Chen, Yangkai Li, Robert B. Petersen, Kun Huang

• Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment

  Author: Wang Manni, Yu Liu, Yuan Cheng, Wei Xiawei, Wei Yuquan

• Advancing the understanding of NAFLD to hepatocellular carcinoma development: From experimental models to humans

  Author: Kan Chen, Jianbo Ma, Xiaoyuan Jia, Wen Ai, Zhongren Ma, Qiuwei Pan

英文介紹

Biochimica Et Biophysica Acta-reviews On Cancer雜志英文介紹

BBA Reviews on Cancer covers the whole field of the biology and biochemistry of cancer, emphasizing oncogenes and tumor suppressor genes, growth-related cell cycle control signalling, carcinogenesis mechanisms, cell transformation, immunologic control mechanisms, genetics of human (mammalian) cancer, control of cell proliferation, genetic and molecular control of organismic development, rational anti-tumor drug design. In short, the journal presents critical invited reviews on new developments in cancer investigation at the molecular level.